Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05911308 |
| Title | Pilot Study of Abequolixron (RGX-104) and Durvalumab in Lung Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | UNC Lineberger Comprehensive Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Moffitt Cancer Center | NOT_YET_RECRUITING | Tampa | Florida | 33612 | United States | Details |
| UNC Lineberger Comprehensive Cancer Center | RECRUITING | Chapel Hill | North Carolina | 27516 | United States | Details |
| Fox Chase Cancer Center | NOT_YET_RECRUITING | Philadelphia | Pennsylvania | 19111 | United States | Details |